Background Co-infection of leishmaniasis and HIV is increasingly reported. The clinical
presentation of leishmaniasis is determined by the host immune response to the parasite; as …

Post‐kala‐azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis
(VL) observed mainly in Sudan and India where it follows treated VL in 50% and 10% of …

Post‐kala‐azar dermal leishmaniasis (PKDL) is a common complication following kala‐azar
(visceral leishmaniasis). In a prospective study in a village in the endemic area for kala‐azar …

Post-kala-azar dermal leishmaniasis (PKDL) is a parasitic skin infection which can occur
after visceral leishmaniasis (VL). Recent xenodiagnosis studies (Mondal et al., Clin. Infect …

Background Post kala azar dermal leishmaniasis (PKDL) is a disease that appears after
treatment of visceral leishmaniasis (VL). The highest incidence of PKDL in the world is in …

Background Few prospective data exist on incidence of post kala-azar dermal leishmaniasis
(PKDL) and visceral leishmaniasis (VL) relapse after different treatment regimens …

Cell-mediated immune (CMI) response in 16 Indian kala-azar (KA) and 12 post-kala-azar
dermal leishmaniasis (PKADL) patients was studied in detail by in vitro lymphocyte …

Post kala-azar dermal leishmaniasis (PKDL) is a dermatosis that occurs as a sequel of
visceral leishmaniasis (VL). Elimination of VL requires detection and treatment of PKDL …

Identification of post‐kala‐azar dermal leishmaniasis (PKDL) is important due to the long
and toxic treatment and the fact that PKDL patients may serve as a reservoir for visceral …

Visceral leishmaniasis (VL) or kala-azar is known to be associated with a mixed Th1-Th2
response, and effective host defense requires the induction of IFN-γ and IL-12. We address …